Design, Synthesis and Cytotoxic Activity of Novel Sulfonylurea Derivatives of Podophyllotoxin

Zhi-Jun Zhang,Jing Tian,Li-Ting Wang,Mei-Juan Wang,Xiang Nan,Liu Yang,Ying-Qian Liu,Susan L. Morris-Natschke,Kuo-Hsiung Lee
DOI: https://doi.org/10.1016/j.bmc.2013.11.035
IF: 3.461
2013-01-01
Bioorganic & Medicinal Chemistry
Abstract:Three series of novel sulfonylurea podophyllotoxin derivatives were designed, synthesized, and evaluated for in vitro cytotoxicity against four tumor cell lines (A-549, DU-145, KB and KBvin). Compounds 14c (IC50: 1.41–1.76μM) and 14e (IC50: 1.72–2.01μM) showed superior cytotoxic activity compared with etoposide (IC50: 2.03 to >20μM), a clinically available anticancer drug. Significantly, most of the compounds exhibited comparable cytotoxicity against the drug-resistant tumor cell line KBvin, while etoposide lost activity completely. Preliminary structure–activity relationship (SAR) correlations indicated that the 4′-O-methyl functionality in podophyllotoxin analogues may be essential to maintain cytotoxic activity, while an arylsulfonylurea side chain at podophyllotoxin’s 4β position can significantly improve cytotoxic activity.
What problem does this paper attempt to address?